Did anyone catch todays Twitter $MNKD chatter?!

[afrezzamiracle]

People were discussing the unusual Q4 2013 regulatory filings by both Novo and Sanofi for 500M shares each.  Yes the exact same number.  All conveniently linked below for your viewing pleasure!:

secfilings.nasdaq.com/filingFrameset.asp?FileName=0001193805-13-002238.txt&FilePath=\2013\12\10\&CoName=NOVO+NORDISK+A+S&FormType=F-6EF&RcvdDate=12%2F10%2F2013&pdf=

secfilings.nasdaq.com/filingFrameset.asp?FileName=0001193805-13-001990.txt&FilePath=\2013\10\31\&CoName=SANOFI&FormType=F-6EF&RcvdDate=10%2F31%2F2013&pdf=

stocktwits.com/TheTruth4All

stocktwits.com/symbol/MNKD

[mnkdd]

Interesting, but each company lists price per share as only 5 cents, so total is only $25 mil? Not sure what they can do with that.

[afrezzamiracle]

The 5 cents is just a fee value estimated solely for the purposes of the small registration fee. The ADR of their stocks are worth a great deal more than that.

[mdcenter61]

A lot of discussion on YMB as well regarding some of the patent interplay between the three companies....time will tell.

[afrezzamiracle]

If we somehow manage to land BOTH Sanofi and Novo as global parners I'm going to have to change my pants! Can you imagine the type of sales this type of arrangement would generate?!

[liane]

Sort of combining this thread with the patent thread... I did some more digging through the patent - trust me - I'm no expert on the lingo. But it seemed to me they were covering every conceivable combo and dosing regime with the RAAs aspart (Novo), glulisine (Sanofi), and lispro (Lilly). Could it be that MNKD supplies inhalable Afrezza dose-packed with your RAA pen for all of these companies. New combo pack - new patent life for all of these drugs. Partner with all of them and everyone wins.